Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2016 1
2017 3
2018 1
2019 1
2021 2
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
PI3K Targeting in Non-solid Cancer.
Kim HN, Ogana H, Sanchez V, Nichols C, Kim YM. Kim HN, et al. Among authors: nichols c. Curr Top Microbiol Immunol. 2022;436:393-407. doi: 10.1007/978-3-031-06566-8_17. Curr Top Microbiol Immunol. 2022. PMID: 36243854 Free PMC article. Review.
Noncanonical microprotein regulation of immunity.
Nichols C, Do-Thi VA, Peltier DC. Nichols C, et al. Mol Ther. 2024 Sep 4;32(9):2905-2929. doi: 10.1016/j.ymthe.2024.05.021. Epub 2024 May 11. Mol Ther. 2024. PMID: 38734902 Review.
Targeting PI3K Signaling in Acute Lymphoblastic Leukemia.
Sanchez VE, Nichols C, Kim HN, Gang EJ, Kim YM. Sanchez VE, et al. Among authors: nichols c. Int J Mol Sci. 2019 Jan 18;20(2):412. doi: 10.3390/ijms20020412. Int J Mol Sci. 2019. PMID: 30669372 Free PMC article. Review.
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
Desai S, Mo C, Gaglione EM, Yuan CM, Stetler-Stevenson M, Tian X, Maric I, Wake L, Farooqui MZ, Drinkwater DC, Soto S, Valdez J, Hughes TE, Nierman P, Lotter J, Marti GE, Pleyer C, Sun C, Superata J, Nichols C, Herman SEM, Lindorfer MA, Taylor RP, Wiestner A, Ahn IE. Desai S, et al. Among authors: nichols c. Leuk Lymphoma. 2021 Aug;62(8):1816-1827. doi: 10.1080/10428194.2021.1888379. Epub 2021 Mar 2. Leuk Lymphoma. 2021. PMID: 33653216 Free PMC article. Clinical Trial.
Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.
Lillo MA, Nichols C, Perry C, Runke S, Krutilina R, Seagroves TN, Miranda-Carboni GA, Krum SA. Lillo MA, et al. Among authors: nichols c. J Appl Toxicol. 2017 Apr;37(4):417-425. doi: 10.1002/jat.3374. Epub 2016 Sep 1. J Appl Toxicol. 2017. PMID: 27581495 Free PMC article.
Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells.
Lillo MA, Nichols C, Seagroves TN, Miranda-Carboni GA, Krum SA. Lillo MA, et al. Among authors: nichols c. Horm Cancer. 2017 Apr;8(2):90-99. doi: 10.1007/s12672-017-0286-5. Epub 2017 Feb 27. Horm Cancer. 2017. PMID: 28244015 Free PMC article.
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia.
Ruan Y, Kim HN, Ogana HA, Wan Z, Hurwitz S, Nichols C, Abdel-Azim N, Coba A, Seo S, Loh YE, Gang EJ, Abdel-Azim H, Hsieh CL, Lieber MR, Parekh C, Pal D, Bhojwani D, Durden DL, Kim YM. Ruan Y, et al. Among authors: nichols c. Front Oncol. 2021 Dec 1;11:766888. doi: 10.3389/fonc.2021.766888. eCollection 2021. Front Oncol. 2021. PMID: 34926269 Free PMC article.
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.
Saba NS, Wong DH, Tanios G, Iyer JR, Lobelle-Rich P, Dadashian EL, Liu D, Fontan L, Flemington EK, Nichols CM, Underbayev C, Safah H, Melnick A, Wiestner A, Herman SEM. Saba NS, et al. Among authors: nichols cm. Cancer Res. 2017 Dec 15;77(24):7038-7048. doi: 10.1158/0008-5472.CAN-17-2485. Epub 2017 Oct 9. Cancer Res. 2017. PMID: 28993409 Free PMC article.
12 results